首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1378760

2023-2028 年按产品与服务、技术（免疫组织化学、聚合酶连锁反应、原位杂交、即时 PCR、基因定序等）、适应症、最终用户和地区分類的伴随诊断市场报告

Companion Diagnostics Market Report by Product & Service, Technology (Immunohistochemistry, Polymerase Chain Reaction, In-situ Hybridization, Real-time PCR, Gene Sequencing, and Others), Indication, End User, and Region 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年全球伴随诊断市场规模达59亿美元。展望未来， IMARC Group预计到2028年市场规模将达到133亿美元，2022-2028年复合年增长率（CAGR）为14.5%。癌症盛行率的不断上升、对个人化医疗的需求激增以及下一代定序（NGS）等持续的技术进步是推动市场发展的一些关键因素。

伴随诊断是帮助医生确定最有效的治疗计划的医学测试。这些测试旨在识别患者组织或血液样本中的特定生物标记物，表明患者是否可能从特定药物或疗法中受益。他们还分析患者的详细生物学特征和作用机制 (MOA)，并协助医疗专业人员了解药物的潜在副作用。伴随诊断广泛应用于个人化药物，因为它考虑每个患者的独特特征，例如他们的基因组成，以确定最佳的治疗计划。除此之外，它们也越来越多地用于测试癌症患者的特定基因突变或丙型肝炎患者的生物标记。这有助于医生针对个别患者制定治疗方案，提高成功结果的可能性并降低副作用的风险。

伴随诊断市场趋势：

全球各种癌症病例的增加推动了对更有效和更有针对性的癌症治疗的需求，这主要推动了市场的成长。伴随诊断有助于识别最有可能从特定癌症治疗中受益的患者，从而获得更好的患者治疗结果。此外，针对每位患者独特特征的个人化药物需求不断增长，正在为市场创造良好的前景。同时，用于治疗多种感染、心血管、神经和发炎疾病的标靶药物和疗法的广泛采用是另一个重要的生长诱导因素。除此之外，随着越来越多的测试获得美国食品和药物管理局 (US FDA) 等管理机构的批准，以及世界各地不断增加的临床试验数量，伴随诊断的有利监管环境正在加强市场成长。此外，诊断技术的不断进步，例如下一代定序（NGS）和液体活检的出现，可以识别以前难以检测的生物标誌物，也有助于市场的成长。除此之外，创新基因组技术的发展使得能够识别基因突变和其他可用于指导治疗决策的生物标誌物，正在推动市场成长。其他因素，例如在药物开发中生物标记物的使用不断增加、对精准医疗的广泛投资以及消费者对伴随诊断的好处的认识不断提高，都为市场带来了有利可图的成长机会。

本报告回答的关键问题

2022 年全球伴随诊断市场规模有多大？
2023-2028年全球伴随诊断市场的预期成长率是多少？
COVID-19 对全球伴随诊断市场有何影响？
推动全球伴随诊断市场的关键因素是什么？
基于产品和服务的全球伴随诊断市场的细分是什么？
基于该技术的全球伴随诊断市场的细分情况如何？
根据该指标，全球伴随诊断市场的细分如何？
基于最终用户的全球伴随诊断市场的细分情况如何？
全球伴随诊断市场的关键区域有哪些？
全球伴随诊断市场的主要参与者/公司有哪些？

免疫组织化学 (IHC)
- 市场走向
- 市场预测
聚合酶炼式反应 (PCR)
- 市场走向
- 市场预测
原位杂交 (ISH)
- 市场走向
- 市场预测
即时萤光定量PCR (RT-PCR)
- 市场走向
- 市场预测
基因定序
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 8 章：按迹象分類的市场

癌症
- 市场走向
- 主要类型
  - 肺癌
  - 乳癌
  - 大肠直肠癌
  - 胃癌
  - 黑色素瘤
  - 其他的
- 市场预测
神经系统疾病
- 市场走向
- 市场预测
传染性疾病
- 市场走向
- 市场预测
心血管疾病
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 9 章：最终用户的市场区隔

製药及生物製药公司
- 市场走向
- 市场预测
参考实验室
- 市场走向
- 市场预测
合约研究组织
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 10 章：按地区分類的市场细分

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太地区
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 11 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 12 章：价值链分析

第 13 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 14 章：价格分析

第15章：竞争格局

市场结构
关键参与者
关键参与者简介
- Abbott Laboratories
- Agilent Technologies
- BioMerieux
- Danaher Corporation
- Roche Holding AG
- Myriad Genetics Inc.
- Siemens Healthcare
- Thermo Fisher Scientific Inc.

简介目录图表

Product Code: SR112023A2548

Abstract

The global companion diagnostics market size reached US$ 5.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 14.5% during 2022-2028. The increasing prevalence of cancer, the surging demand for personalized medicine, and ongoing technological advancements, such as next-generation sequencing (NGS), represent some of the key factors driving the market.

Companion diagnostics are medical tests that help physicians determine the most effective treatment plan. These tests are designed to identify specific biomarkers in a patient's tissue or blood sample, indicating whether the patient will likely benefit from a particular drug or therapy. They also analyze the detailed biological profile and the mechanism of action (MOA) of patients and assist medical professionals in understanding the potential side effects of medications. Companion diagnostics are widely used across personalized medicines as it considers each patient's unique characteristics, such as their genetic makeup, to determine the best treatment plan. In addition to this, they are increasingly used for testing specific genetic mutations in cancer patients or biomarkers in patients with hepatitis C. This helps physicians tailor treatments to individual patients, improving the likelihood of successful outcomes and reducing the risk of side effects.

Companion Diagnostics Market Trends:

The rising instances of various kinds of cancer across the globe are impelling the demand for more effective and targeted cancer treatments, which is primarily driving the market growth. Companion diagnostics help identify patients who are most likely to benefit from specific cancer therapies, resulting in better patient outcomes. Moreover, the growing demand for personalized medicines tailored to each patient's unique characteristics is creating a favorable outlook for the market. Concurrent with this, the widespread adoption of targeted drugs and therapies for treating numerous infectious, cardiovascular, neurological, and inflammatory conditions is acting as another significant growth-inducing factor. In addition to this, the favorable regulatory landscape for companion diagnostics, with an increasing number of tests receiving approval from governing authorities such as the United States Food and Drug Administration (US FDA), and the expanding number of clinical trials around the world are strengthening the market growth. Furthermore, ongoing advancements in diagnostic technologies, such as the emergence of next-generation sequencing (NGS) and liquid biopsy, which have allowed identifying biomarkers that were formerly difficult to detect, are contributing to the market growth. Besides this, the development of innovative genomic technologies, which have enabled the identification of genetic mutations and other biomarkers that can be used to guide treatment decisions, is fueling the market growth. Other factors, such as the rising use of biomarkers in drug development, extensive investments in precision medicine, and the escalating consumer awareness regarding the benefits of companion diagnostics, are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product & service, technology, indication, and end user.

Product & Service Insights:

Assays, Kits and Reagents

Software and Services

The report has provided a detailed breakup and analysis of the companion diagnostics market based on the product & service. This includes assays, kits and reagents, and software and services. According to the report, assays, kits, and reagents represented the largest segment.

Technology Insights:

Immunohistochemistry (IHC)

Polymerase Chain Reaction (PCR)

In-situ Hybridization (ISH)

Real-time PCR (RT-PCR)

Gene Sequencing

Others

A detailed breakup and analysis of the companion diagnostics market based on technology has also been provided in the report. This includes immunohistochemistry (IHC), polymerase chain reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), gene sequencing, and others. According to the report, polymerase chain reaction (PCR) accounted for the largest market share.

Indication Insights:

Cancer

Lung Cancer

Breast Cancer

Colorectal Cancer

Gastric Cancer

Melanoma

Others

Neurological Diseases

Infectious Diseases

Cardiovascular Diseases

Others

The report has provided a detailed breakup and analysis of the companion diagnostics market based on the indication. This includes cancer (lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, and others), neurological diseases, infectious diseases, cardiovascular diseases, and others. According to the report, cancer represented the largest segment.

End User Insights:

Pharmaceutical & Biopharmaceutical Companies

Reference Laboratories

Contract Research Organizations

Others

A detailed breakup and analysis of the companion diagnostics market based on the end user has also been provided in the report. This includes pharmaceutical & biopharmaceutical companies, reference laboratories, contract research organizations, and others. According to the report, pharmaceutical & biopharmaceutical companies accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for companion diagnostics. Some of the factors driving the North America companion diagnostics market included the growing prevalence of cancer, the rising adoption of personalized medicines and targeted therapies, and significant advancements in next-generation sequencing (NGS).

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global companion diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare, and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global companion diagnostics market in 2022?
2. What is the expected growth rate of the global companion diagnostics market during 2023-2028?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product & service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Companion Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product & Service

6.1 Assays, Kits and Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Software and Services
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Immunohistochemistry (IHC)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Real-time PCR (RT-PCR)
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Gene Sequencing
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Indication

8.1 Cancer
- 8.1.1 Market Trends
- 8.1.2 Major Types
  - 8.1.2.1 Lung Cancer
  - 8.1.2.2 Breast Cancer
  - 8.1.2.3 Colorectal Cancer
  - 8.1.2.4 Gastric Cancer
  - 8.1.2.5 Melanoma
  - 8.1.2.6 Others
- 8.1.3 Market Forecast
8.2 Neurological Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Infectious Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Cardiovascular Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical & Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Reference Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Contract Research Organizations
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 BioMerieux
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Danaher Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Roche Holding AG
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 SWOT Analysis
- 15.3.6 Myriad Genetics Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Siemens Healthcare
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Thermo Fisher Scientific Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2022
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2022
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2022
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Companion Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 93: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Companion Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2023-2028
Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Companion Diagnostics Market Structure
Table 8: Global: Companion Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219